Effect of the protease inhibitor MG132 on the transforming growth factor-β/Smad signaling pathway in HSC-T6 cells

Abstract

The activation of hepatic stellate cells (HSCs) and their transformation to myofibroblasts are the key steps in the pathological progress of liver fibrosis. The transforming growth factor-β (TGFβ)/Smad pathway is involved in the proliferation and collagen synthesis of HSCs. This study aimed to examine the effect of the protease inhibitor MG132 on the signaling pathway of TGFβ/Smad in HSC-T6 cells and seek a novel therapeutic approach for liver fibrosis. The HSC-T6 cells were treated with MG132 at different concentrations (0–10 μmol/L). Cell proliferation was detected by MTT method. The mRNA and protein expression levels of TGFβ1, Smad3 and Smad7 were determined in HSC-T6 cells by real-time PCR and Western blotting, respectively, after treatment with MG132 at different concentrations (1, 2, 3 μmol/L) or RPMI1640 alone (serving as control). The results showed that MG132 could inhibit the proliferation of HSC-T6 cells in a dose-dependent manner, and the IC₅₀ of MG132 was 6.84 μmol/L. After treatment with MG132 at 1, 2 or 3 μmol/L for 24 h, the mRNA expression levels of TGF-β1 and Smad3 were significantly decreased (P<0.05), but the Smad7 mRNA expression had no significant change (P>0.05). There was also a significant decrease in the protein expression level of TGF-β1 and Smad3 (P<0.05). However, the expression of Smad7 protein was substantially increased when compared with the control group (P<0.05). It was concluded that the inhibition of TGFβ/Smad pathway in HSC-T6 cells by MG132 can reduce the production of profibrosis factors (TGFβ1, Smad3) and promote the expression of anti-fibrosis factor (Smad7), suggesting that MG132 may become a potential therapeutic alternative for liver fibrosis.

Keywords

liver fibrosis / TGFβ/Smad pathway / MG132 / HSC-T6

References

[1] FriedmanSL. Mechanisms of hepatic fibrogenesis. Gastroenterology, 2008, 134(6): 1655-1669

[2] FriedmanSL. Hepatic fibrosis-overview. Toxicology, 2008, 254(3): 120-129

[3] ArthurMJ. Reversibility of liver fibrosis and cirrhosis following treatment for hepatitis C. Gastroenterology, 2002, 122(5): 1525-1528

[4] IredaleJP, BenyonRC, PickeringJ, et al.. Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors. J Clin Invest, 1998, 102(3): 538-549

[5] IredaleJP. Hepatic stellate cell behavior during resolution of liver injury. Semin Liver Dis, 2001, 21(3): 427-436

[6] KavsakP, RasmussenRK, CausingCG, et al.. Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF beta receptor for degradation. Mol Cell, 2000, 6(6): 1365-1375

[7] SchuppanD, AfdhalNH. Liver cirrhosis. Lancet, 2008, 371(9615): 838-851

[8] KisselevaT, BrennerDA. Mechanisms of fibrogenesis. Exp Biol Med, 2008, 233(2): 109-122

[9] FlandersKC. Smad3 as a mediator of the fibrotic response. Int J Exp Pathol, 2004, 85(2): 47-64

[10] PfafflMW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res, 2001, 29(9): e45

[11] WangC, KimT, GaoD, et al.. Rapid high-yield mRNA extraction for reverse-transcription PCR. J Biochem Biophys Methods, 2007, 70(3): 507-509

[12] KaimoriA, PotterJ, KaimoriJY, et al.. Transforming growth factor-β1 induces an epithelial-to-mesenchymal transition state in mouse hepatocytes in vitro. J Biol Chem, 2007, 282(30): 22089-22101

[13] InagakiY, OkazakiI. Emerging insights into transforming growth factor-β/Smad signal in hepatic fibrogenesis. Gut, 2007, 56(2): 284-292

[14] DooleyS, Ten DijkeP. TGF-β in progression of liver disease. Cell Tissue Res, 2012, 347(1): 245-256

[15] UemuraM, SwensonES, GacaMD, et al.. Smad2 and Smad3 play different roles in rat hepatic stellate cell function and α-smooth muscle actin organization. Mol Biol Cell, 2005, 16(9): 4214-4224

[16] WangJ, MaldonadoMA. The ubiquitin-proteasome system and its role in inflammatory and autoimmune diseases. Cell Mol Immunol, 2006, 3(4): 255-261

[17] LiuX, WenFQ, KobayashiT, et al.. Smad3 mediates the TGF-beta-induced contraction of type I collagen gels by mouse embryo fibroblasts. Cell Motil Cytoskeleton, 2003, 54(3): 248-253

[18] DooleyS, HamzaviJ, BreitkopfK, et al.. Smad7 prevents activation of hepatic stellate cells and liver fibrosis in rats. Gastroenterology, 2003, 125(1): 178-191

[19] ZhangF, LaihoM. On and off: proteasome and TGF-beta signaling. Exp Cell Res, 2003, 291(2): 275-281

[20] SchnablB, KweonYO, FrederickJP, et al.. The role of Smad3 in mediating mouse hepatic stellate cell activation. Hepatology, 2001, 34(1): 89-100